Gefurulimab (ALXN-1720) is a human-derived bispecific antibody that targets complement C5 and albumin, specifically binding to C5 to inhibit its activation [1].
CAS Number:
[2456407-94-4]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted